Tectonic appoints François Nader as independent director and Chair; McGuire steps down

Tectonic Therapeutic, Inc.

François Nader, M.D., appointed to board effective Apr 1, 2026; assumes Chair role same date.
Current Chair Terry McGuire resigns as Chair Apr 1, remains board member until June 2026 annual meeting.
Nader is independent director at Moderna (MRNA); led multiple biotech acquisitions (Acceleron, Alexion).
Company posted presentation on TX2100 for HHT and bleeding disorders (no new clinical data).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.